XML 44 R33.htm IDEA: XBRL DOCUMENT v3.25.3
EQUITY AND NONCONTROLLING INTERESTS (Tables)
 9 Months Ended
Sep. 27, 2025
Equity [Abstract]  
Schedule of Reconciliation of the Numerator and Denominator in the Computations of the Basic and Diluted Earnings Per Share
The following table reconciles the numerator and denominator in the computations of basic and diluted earnings per share:
Three Months EndedNine Months Ended
September 27, 2025September 28, 2024September 27, 2025September 28, 2024
(in thousands)
Numerator:  
Net income$55,556 $70,295 $134,127 $239,038 
Less: Net income attributable to noncontrolling interests1,134 638 1,910 2,340 
Net income attributable to Charles River Laboratories International, Inc.54,422 69,657 132,217 236,698 
Calculation of net income per share attributable to Charles River Laboratories International, Inc. common shareholders
Net income attributable to Charles River Laboratories International, Inc.$54,422 $69,657 $132,217 $236,698 
Less: Adjustment of redeemable noncontrolling interest (1)
— 379 — 1,081 
Less: Incremental dividends attributable to noncontrolling interest holders (2)
— 599 — 9,621 
Net income available to Charles River Laboratories International, Inc. common shareholders$54,422 $68,679 $132,217 $225,996 
Denominator:  
Weighted-average shares outstanding - Basic49,213 51,394 49,680 51,461 
Effect of dilutive securities:
Stock options, restricted stock units and performance share units213 189 186 252 
Weighted-average shares outstanding - Diluted49,426 51,583 49,866 51,713 
Anti-dilutive common stock equivalents (3)(4)
1,131 746 1,057 505 
(1) Represents adjustments of redeemable noncontrolling interest that impact retained earnings.
(2) Represents incremental declared dividends attributable to Noveprim noncontrolling interest holders who are entitled to preferential dividends for fiscal year 2024.
(3) Anti-dilutive common stock equivalents represent amounts outstanding related to employee stock options, RSUs and PSUs for all periods presented.
(4) These common stock equivalents were outstanding for the periods presented, but were not included in the computation of diluted EPS for those periods because their inclusion would have had an anti-dilutive effect.
Schedule of Accumulated Other Comprehensive Income (Loss)
Changes to each component of accumulated other comprehensive income (loss), net of income taxes, are as follows:
Foreign Currency Translation Adjustment
and Other 		Pension and Other Post-Retirement Benefit PlansTotal
(in thousands)
December 28, 2024$(261,471)$(55,874)$(317,345)
Other comprehensive income before reclassifications
153,369 1,327 154,696 
Net current period other comprehensive income
153,369 1,327 154,696 
Income tax expense28,640 327 28,967 
September 27, 2025$(136,742)$(54,874)$(191,616)